Silvija Miletić  Gršković

Dr. Silvija Miletić Gršković

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
AKAntea Krsek
Antea Krsek
LBLara Baticic
Lara Baticic
BĆBožena Ćurko-Cofek
Božena Ćurko-Cofek
TBTanja Batinac
Tanja Batinac
GLGordana Laškarin
Gordana Laškarin
VSVlatka Sotošek
Vlatka Sotošek
The endothelial glycocalyx (EGC) is a layer of proteoglycans (associated with glycosaminoglycans) and glycoproteins, which adsorbs plasma proteins on the luminal surface of endothelial cells. Its main function is to participate in separating the circulating blood from the inner layers of the vessels and the surrounding tissues. Physiologically, the EGC stimulates mechanotransduction, the endothelial charge, thrombocyte adhesion, leukocyte tissue recruitment, and molecule extravasation. Hence, severe impairment of the EGC has been implicated in various pathological conditions, including sepsis, diabetes, chronic kidney disease, inflammatory disorders, hypernatremia, hypervolemia, atherosclerosis, and ischemia/reperfusion injury. Moreover, alterations in EGC have been associated with altered responses to therapeutic interventions in conditions such as cardiovascular diseases. Investigation into the function of the glycocalyx has expanded knowledge about vascular disorders and indicated the need to consider new approaches in the treatment of severe endothelial dysfunction. This review aims to present the current understanding of the molecular mechanisms underlying cardiovascular diseases and to elucidate the impact of heart surgery on EGC dysfunction.

10 October 2012 in Neurological Sciences
Verified
Journal Article
Closed access
PDF file
IMIva Milivojević
Iva Milivojević
ŽBŽarko Bakran
Žarko Bakran
IAIvan Adamec
Ivan Adamec
SGSilvija Miletić Gršković
Silvija Miletić Gršković
Mario HabekMario Habek
Mario Habek

1 April 2019 in Cardiologia Croatica
Verified
Journal Article
Closed access
SGSilvija Miletić Gršković
Silvija Miletić Gršković
VBVedran Buršić
Vedran Buršić
ATAdrian Trobonjača
Adrian Trobonjača
VPViktor Peršić
Viktor Peršić


2 August 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SGSilvija Miletić Gršković
Silvija Miletić Gršković
IBIva Uravić Bursać
Iva Uravić Bursać
VŠVedrana Tudor Špalj
Vedrana Tudor Špalj
VDVedrana Drvar
Vedrana Drvar
VSVlatka Sotošek
Vlatka Sotošek
GLGordana Laškarin
Gordana Laškarin
Background/Objectives: Vitamin D insufficiency is common in patients with spondyloarthritis (SpA). We analyzed the relationship between vitamin D, disease activity, and left ventricular (LV) function in patients with SpA. Methods: A total of 298 patients with SpA and 57 healthy controls were enrolled. Serum vitamin D and laboratory cardiovascular risk factors were analyzed, and LV function was assessed by echocardiography. Vitamin D, the Ankylosing Spondylitis Disease Activity Score (ASDAS), and the Disease Activity Index for Psoriatic Arthritis (DAPSA) were examined for mutual correlations using univariate and multivariate linear regression models and were compared between groups. Results: Vitamin D levels did not differ between the SpA group and controls, although vitamin D supplementation was more frequent among SpA patients. Vitamin D was not associated with SpA activity. ASDAS and DAPSA were positively correlated with isovolumic relaxation time, and DAPSA was inversely correlated with peak early diastolic mitral annular velocity (e′), after adjustment for age, sex, metabolic factors, and/or therapy. Patients with insufficient serum vitamin D levels (<75 nmol/L) showed greater impairment of systolic and diastolic LV function and a diabetic-like lipid profile compared with those with sufficient vitamin D levels. The e′ wave was positively correlated with vitamin D after controlling for confounding factors. These findings in patients with SpA are consistent with those previously reported in patients with psoriatic arthritis (PsA). Conclusions: Patients with SpA were characterized by vitamin D supplementation, increased disease activity parameters, and impaired LV function. SpA activity, independent of vitamin D, was associated with LV functional impairment, and vitamin D was associated with an increase in the e′ wave after adjustment for confounding factors. However, causal inferences cannot be drawn from correlational analyses.